Recombitek 4 Lepto - 2668.00
63 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
63
Total Reports
6
Deaths Reported
950.0%
Death Rate
Active Ingredients
Recombitek 4 Lepto - 2668.00
Administration Routes
SubcutaneousUnknownIntramuscular
Species Affected
Dog 63
Most Affected Breeds
Retriever - Labrador 10
Shih Tzu 6
Crossbred Canine/dog 5
Retriever - Golden 4
Beagle 4
Chihuahua 4
Rottweiler 3
Bulldog - French 3
Ridgeback - Rhodesian 2
Terrier - Yorkshire 2
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 20
Vomiting 17
Anorexia 12
Other abnormal test result NOS 7
Seizure NOS 7
Not eating 6
Anaemia NOS 5
Elevated alanine aminotransferase (ALT) 5
Injection site swelling 4
Elevated serum alkaline phosphatase (SAP) 4
Diarrhoea 4
Behavioural disorder NOS 4
Outcome Breakdown
Recovered/Normal
25 (39.1%)
Outcome Unknown
23 (35.9%)
Ongoing
9 (14.1%)
Died
5 (7.8%)
Euthanized
2 (3.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.